A significant advance in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer suppressor protein is frequently lost in several forms of tumors, https://keybookmarks.com/story21967606/nanobodies-reactivate-the-p53-protein-new-new-approach-for-malignant-management